$AGN Recent News In focus: Challenging the all-time

New Post Public Reply Private Reply Replies (0) Message Board

Apr 25, 2014 at 11:45 AM

$AGN Recent News

In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off-the-radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan soars on Valeant bid; Netflix jumps on results 3:12 p.m. April 22, 2014 - Saumya Vaishampayan
Investors anticipate higher Allergan bids amid Valeant's hostile takeover 12:27 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan surges 15% on Valeant offer 9:32 a.m. April 22, 2014 - Sue Chang
Bear call on GE, wads of drug(maker) cash, Netflix price hike 9:26 a.m. April 22, 2014 - blogs.marketwatch.com
Stock futures edge higher; Allergan jumps on deal news 8:59 a.m. April 22, 2014 - Sara Sjolin
Valeant, Ackman propose Allergan deal 8:13 a.m. April 22, 2014 - David Benoit
Allergan, Valeant shares rally on buyout offer 8:02 a.m. April 22, 2014 - Ben Eisen
Valeant: 0.83 share plus $48.30 per Allergan share 7:48 a.m. April 22, 2014 - Ben Eisen
McDonald’s, Gilead, Yum, AT&T are stocks to watch 5:56 a.m. April 22, 2014 - Sue Chang
Valeant's ravenous buyout appetite reappears with Allergan proposal 6:38 p.m. April 21, 2014 - blogs.marketwatch.com

Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal 49 min ago - GuruFocus.com
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. Today - Zacks.com
Allergan Leads 30 Best Value Bond Trades With Maturities Of 1 Year Or More, April 24 9:10 p.m. April 24, 2014 - Seeking Alpha
Update on Glaxo/Theravance's COPD Drugs - Analyst Blog 6:33 p.m. April 24, 2014 - Zacks.com
Valeant Eyes Allergan - Analyst Blog 5:40 p.m. April 24, 2014 - Zacks.com
Allergan Investor Doesn't Favor Offer 5:25 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:16 p.m. April 24, 2014 - CNW Group
Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog 1:50 p.m. April 24, 2014 - Zacks.com
Zimmer Bolts on Biomet for $13.4B 11:47 a.m. April 24, 2014 - TheStreet.com
Botox at the Center of Recent Healthcare M&A Flurry 11:07 a.m. April 24, 2014 - TheStreet.com
Cramer's Mad Money - Why Isn't The Selling More Pronounced (4/23/14) 5:57 a.m. April 24, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's New Reality 8:20 p.m. April 23, 2014 - TheStreet.com
Encouraging Results from Pfizer's Xeljanz - Analyst Blog 6:20 p.m. April 23, 2014 - Zacks.com
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen 6:03 p.m. April 23, 2014 - GuruFocus.com
Three Valeant Directors Won't Be Nominated for Re-Election 5:21 p.m. April 23, 2014 - The Wall Street Journal Interactive Edition
Allergan Inc (AGN): Today's Featured Drugs Winner 5:00 p.m. April 23, 2014 - TheStreet.com
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium 3:46 p.m. April 23, 2014 - GuruFocus.com
Biggest Movers in Healthcare Stocks Now – QCOR AGN IDXX WCG 1:45 p.m. April 23, 2014 - InvestorPlace.com
Follow the Leaders Today 1:00 p.m. April 23, 2014 - RealMoney.com
Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan 10:25 a.m. April 23, 2014 - Wall St. Cheat Sheet

Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. Today - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
Allergan Announces Quarterly Conference Call 5:30 p.m. April 4, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

O-I Glass Faces Legal Storm Over Misleading Investor Claims

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Navigating Simultaneous Home Buy and Sell Strategies

Juggling Two Housing Transactions You ever tried juggling chainsaws? That's what buying and selling your home at the same time can feel like. Selling First: Playing It Safe Some folks swear by selling their current home first, and there's good reason. It locks in your financial windfall, giving you a clear picture of your down payment and affordability. No more guessing...

VILVA's Global Reach: Power Testing's Next Phase

A Power Play on Global Markets Taking a page from its relentless pursuit of quality and innovation, VILVA Electronics is bolstering its foothold on the international stage. Based in Shenzhen, this savvy player is reaching out for strategic partners like fishing for that perfect bite, hoping to reel in catches that understand the nitty-gritty of the local ponds—their...

Greenberg Traurig Expands Franchise Team with Tuneski

DC’s Legal Landscape Shifts with Tuneski’s Move Greenberg Traurig's Washington, D.C., office just dialed it up a notch by bringing in Alexander Tuneski. A guy like this crossing the floor from DLA Piper is big news. This isn’t just any legal bean counter; with over 20 years under his belt, Tuneski knows franchise law like the back of his hand. And when you've been...

Enghouse Acquires MIND CTI: Strategic Telecom Play

Enghouse's Strategic Move into Telecom You want a real shake-up in the telecom space? Here it is. Enghouse Systems Limited (TSX: ENGH) is stepping up its game by acquiring MIND C.T.I. Ltd. (NASDAQ: MNDO). This cash-only transaction is tailored to broaden Enghouse’s suite of offerings in telecom and enterprise unified communications (UC). The price? A neat US$1.30 per...

Cognizant Boosts Claude AI with 25,000 Pro Workforce

Moving AI from Theory to Practice You know, AI isn't about just keeping up with the hype; it's about shoving those algorithms right where they can do the most good—right at the core of business operations. And that’s precisely what Cognizant's cooking up with their fresh-off-the-press Claude Frontier Capability Group. They’ve thrown more than 25,000 pros into the...

LG Wins CES Honor with Breakthrough Battery Diagnostic Tech

Speeding Up Diagnostics: A Major Leap Forward In a world where every second counts, LG Energy Solution strikes gold with their latest innovation, Re.Pulse. CES Innovation Awards 2027 has honored LG for this slick piece of tech that trims down battery diagnosis time from a snail's pace seven hours to a lightning-fast 10 minutes. It's not just about speed—it’s also...

QVC Group Readies 2026 Q3 Results, Faces Retail Shift

The Changing Faces of QVC Group Something tells me that the retail landscape’s a different beast in 2026. QVC Group, Inc. (NASDAQ:QVCG) has wired up for a crucial update we’ve all been waiting for—announcing their third quarter fiscal 2026 results. Mark your calendars for November 16th, because that’s when the SEC will get their hands on the 10-Q, and we’ll get...

Election Fallout: Middle-Class Split Persists Despite Votes

The Unseen Election Loser: Middle-Class Unity Seems like every four years, Americans shuffle the seats of power, but Paul Eckert believes the real problem isn't chairs changing; it's the folks sitting in them. With his book, "Healing Middle-Class Democracy," Eckert tackles a split as old as time—or at least since the '80s: the fracture within the middle class....

Dr. Ellen Dorsey Sparks $40 Trillion Climate Shift

A Game Changer in Climate Finance Take a second to wrap your head around this: Dr. Ellen Dorsey is spearheading a movement that's managed to wrangle a whopping $40 trillion. We're talking about a capital shift from fossil fuels to climate solutions. Her leadership at the Wallace Global Fund (WGF) is no small part due to why she's made it to TIME's 2026 TIME100 Climate...